SOMA COMPOUND W Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Soma Compound W, and when can generic versions of Soma Compound W launch?
Soma Compound W is a drug marketed by Meda Pharms and is included in one NDA.
The generic ingredient in SOMA COMPOUND W is aspirin; carisoprodol; codeine phosphate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SOMA COMPOUND W?
- What are the global sales for SOMA COMPOUND W?
- What is Average Wholesale Price for SOMA COMPOUND W?
Summary for SOMA COMPOUND W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | SOMA COMPOUND W at DailyMed |
US Patents and Regulatory Information for SOMA COMPOUND W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meda Pharms | SOMA COMPOUND W/ CODEINE | aspirin; carisoprodol; codeine phosphate | TABLET;ORAL | 012366-002 | Jul 11, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
